CRAMP

General Information


DRACP ID  DRACP00012

Peptide Name   CRAMP

Sequence  ISRLAGLLRKGGEKIGEKLKKIGQKIKNFFQKLVPQPE

Sequence Length  38

UniProt ID  Not available

PubChem CID  Not available

Origin  Mus musculus

Type  Native peptide

Classification

  

Active ACP Membrane-targeted



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
K562 Blast phase chronic myelogenous leukemia, BCR-ABL14 positive; Chronic myeloid leukemia Leukemia IC50=28 µM MTT assay 3 days 1
Jurkat E6.1 Childhood T acute lymphoblastic leukemia; Precursor T-cell acute lymphoblastic leukemia Leukemia IC50=16 µM MTT assay 3 days 1
A549 Lung adenocarcinoma Carcinoma IC50=22 µM MTT assay 3 days 1

Hemolytic Activity  Human erythrocytes: 2% Hemolysis=100 µM

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00012

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C197H338N56O50

Absent amino acids  CDHMTWY

Common amino acids  K

Mass  495135

Pl  11.25

Basic residues  10

Acidic residues  3

Hydrophobic residues  13

Net charge  7

Boman Index  -6054

Hydrophobicity  -58.16

Aliphatic Index  102.63

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  7

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 10973820

Title  CRAMP analogues having potent antibiotic activity against bacterial, fungal, and tumor cells without hemolytic activity

Doi 10.1006/bbrc.2000.3269

Year  2000

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.